47.88
+0.10
+(0.21%)
At close: April 17 at 5:15:51 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
265,741
265,741
205,005
199,381
255,326
Cost of Revenue
101,241
101,241
90,069
101,636
89,445
Gross Profit
164,500
164,500
114,936
97,745
165,881
Operating Expense
214,511
214,511
162,603
99,033
77,207
Operating Income
-50,011
-50,011
-47,667
-1,288
88,674
Net Non Operating Interest Income Expense
6,801
6,801
4,894
7,244
-1,732
Pretax Income
-42,408
-42,408
-42,904
6,259
87,100
Tax Provision
-5,910
-5,910
1,620
1,949
19,161
Net Income Common Stockholders
-36,498
-36,498
-44,524
4,310
67,938
Diluted NI Available to Com Stockholders
-36,498
-36,498
-44,524
4,310
67,938
Basic EPS
-2.20
-2.20
-2.90
0.26
4.16
Diluted EPS
-2.20
-2.20
-2.90
0.26
4.16
Basic Average Shares
16,303.77
16,303.77
15,170.73
16,349.70
16,349.70
Diluted Average Shares
16,303.77
16,303.77
15,170.73
16,349.70
16,349.70
Total Expenses
315,752
315,752
252,672
200,669
166,652
Net Income from Continuing & Discontinued Operation
-36,498
-36,498
-44,524
4,310
67,938
Normalized Income
-36,498
-36,498
-44,524
4,310
67,938
Interest Income
8,050
8,050
4,694
204
6
Interest Expense
6,591
6,591
4,890
1,520
1,686
Net Interest Income
6,801
6,801
4,894
7,244
-1,732
EBIT
-35,817
-35,817
-38,014
7,779
88,786
EBITDA
-20,062
-20,062
-28,064
14,664
98,901
Reconciled Cost of Revenue
101,241
101,241
90,069
101,636
89,445
Reconciled Depreciation
15,755
15,755
9,950
6,885
10,115
Net Income from Continuing Operation Net Minority Interest
-36,498
-36,498
-44,524
4,310
67,938
Normalized EBITDA
-20,062
-20,062
-28,064
14,664
98,901
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 4/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1JK.F Apellis Pharmaceuticals, Inc.
15.39
-2.87%
FYB.DE Formycon AG
22.95
-1.71%
AYJ.F Valneva SE
3.0440
+0.46%
0QF.F Moderna, Inc.
21.84
-0.75%
ABVX.PA ABIVAX Société Anonyme
5.24
-0.19%
22UA.DE BioNTech SE
85.55
-1.67%
MREO Mereo BioPharma Group plc
2.3000
+7.98%
SRRK Scholar Rock Holding Corporation
30.75
+3.33%
APLS Apellis Pharmaceuticals, Inc.
18.20
+0.22%
BNTX BioNTech SE
98.76
+0.52%